Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch Health Boosts Ad Spending For Expanding Supplement Lineup

Executive Summary

Canadian firm, recently renamed from Valeant Pharmaceuticals International, includes launches of Ocuvite Blue Light and PreserVision AREDS 2 Formula Chewable vitamins among its reasons for increasing its consumer health advertising spending. Q2 revenues for its consumer health segment were up 5% organically to $369m.

Advertisement

Related Content

Health, Beauty And Wellness News: Ocuvite Blue Light, NIH Herbal App
Debt-laden Valeant Sells Its Assets, More Divestments Likely
Former Valeant, Philidor Execs Charged With Elaborate Kickback Scheme

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS121769

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel